Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accenture plcACN · Entity 2893 | Group Chief Exec - Health & PS | February 14, 2020 | February 19, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accenture plc
Report date February 14, 2020 · Filed February 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 22,474 |
Reported balance
After 2020-02-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-02-14 · Grant · Acquired 23 · Balance 22,474 F1: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. |
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 22,469 |
Reported balance
After 2020-02-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-02-14 · Tax withholding · Disposed 5 · Balance 22,469 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Accenture Holdings plc
Report date March 12, 2018 · Filed March 13, 2018
Section 16 reporting ended · disclosed 2018-03-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-03-12 transaction · row 1
1 source rowRow 1 · 2018-03-12 · Disposition to issuer · Disposed 2,000 · Balance 0 F1: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2020 Filed Feb 19, 2020 21:12 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 5 | $212.44 | $1,062.21 |
DisclosureSEC source: 0001467373-20-000128 · wf-form4_158214673290276.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,469 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:12 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-20-000128 · wf-form4_158214673290276.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,474 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 21:21 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 959 | $206.81 | $198,334.43 |
DisclosureSEC source: 0001467373-20-000071 · wf-form4_158085130018792.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,451 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:16 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,783 | $209.71 | $373,904.55 |
DisclosureSEC source: 0001467373-20-000031 · wf-form4_157981417579974.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,410 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $209.52 to $210.065. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:16 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 6,316 | $209.10 | $1,320,696.44 |
DisclosureSEC source: 0001467373-20-000031 · wf-form4_157981417579974.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,193 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $208.51 to $209.495. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:16 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 301 | $208.03 | $62,617.15 |
DisclosureSEC source: 0001467373-20-000031 · wf-form4_157981417579974.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,509 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $207.50 to $208.265. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2020 Filed Jan 7, 2020 13:01 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 669 | $208.81 | $139,695.56 |
DisclosureSEC source: 0001467373-20-000018 · wf-form4_157840208155699.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,810 Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 23:21 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 577 | $210.25 | $121,312.87 |
DisclosureSEC source: 0001467373-20-000006 · wf-form4_157809367940783.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,479 Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 23:21 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 3,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-20-000006 · wf-form4_157809367940783.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,056 F1 · kind: Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:17 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 32 | $196.69 | $6,293.92 |
DisclosureSEC source: 0001467373-19-000361 · wf-form4_157419820491186.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,489 Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:17 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000361 · wf-form4_157419820491186.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,521 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 21:21 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 141 | $186.74 | $26,330.34 |
DisclosureSEC source: 0001467373-19-000347 · wf-form4_157307530399361.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,425 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 20:11 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 331 | $186.88 | $61,857.31 |
DisclosureSEC source: 0001467373-19-000334 · wf-form4_157203425034433.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,284 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $186.86 to $186.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 20:11 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,083 | $186.18 | $387,815.86 |
DisclosureSEC source: 0001467373-19-000334 · wf-form4_157203425034433.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,615 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $185.81 to $186.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 20:11 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 3,007 | $185.21 | $556,930.08 |
DisclosureSEC source: 0001467373-19-000334 · wf-form4_157203425034433.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,698 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $184.79 to $185.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 23:03 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 7,748 | $185.23 | $1,435,123.30 |
DisclosureSEC source: 0001467373-19-000321 · wf-form4_157195812625649.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,705 Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 23:03 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 17,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000321 · wf-form4_157195812625649.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,453 Read SEC document |
| October 05, 2019 Filed Oct 8, 2019 20:08 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 139 | $187.96 | $26,126.44 |
DisclosureSEC source: 0001467373-19-000291 · wf-form4_157056526185415.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,282 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 12:10 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 132 | $199.13 | $26,284.50 |
DisclosureSEC source: 0001467373-19-000265 · wf-form4_156803103009499.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,143 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 12:31 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 260 | $189.04 | $49,150.01 |
DisclosureSEC source: 0001467373-19-000250 · wf-form4_156518104715325.xml · nonDerivative · entry 4 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,011 F2 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F5 · price: The transaction was executed in multiple trades at prices ranging from $188.75 to $189.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 12:31 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,435 | $188.09 | $269,903.12 |
DisclosureSEC source: 0001467373-19-000250 · wf-form4_156518104715325.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,271 F2 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $187.67 to $188.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 12:31 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 588 | $187.43 | $110,210.49 |
DisclosureSEC source: 0001467373-19-000250 · wf-form4_156518104715325.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,706 F2 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $186.67 to $187.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 12:31 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 140 | $187.62 | $26,266.10 |
DisclosureSEC source: 0001467373-19-000250 · wf-form4_156518104715325.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,294 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 20:23 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 138 | $190.00 | $26,219.31 |
DisclosureSEC source: 0001467373-19-000225 · wf-form4_156261737679103.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,154 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 13:10 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 147 | $179.37 | $26,367.39 |
DisclosureSEC source: 0001467373-19-000205 · wf-form4_155991298617297.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,016 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| May 15, 2019 Filed May 17, 2019 13:04 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000184 · wf-form4_155809827225009.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,869 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| May 05, 2019 Filed May 6, 2019 20:11 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 147 | $177.24 | $26,054.04 |
DisclosureSEC source: 0001467373-19-000171 · wf-form4_155717349812717.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,817 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| April 22, 2019 Filed Apr 24, 2019 20:18 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,042 | $177.79 | $363,042.08 |
DisclosureSEC source: 0001467373-19-000159 · wf-form4_155613711216110.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,670 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $177.33 to $178.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 20:26 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 147 | $177.73 | $26,126.31 |
DisclosureSEC source: 0001467373-19-000138 · wf-form4_155475517826870.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,712 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 22:23 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 161 | $163.22 | $26,277.62 |
DisclosureSEC source: 0001467373-19-000118 · wf-form4_155191101807079.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,565 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 21:40 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 167 | $156.98 | $26,215.66 |
DisclosureSEC source: 0001467373-19-000086 · wf-form4_154948921549010.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,404 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:19 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 1,607 | $154.44 | $248,185.08 |
DisclosureSEC source: 0001467373-19-000068 · wf-form4_154940155312270.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,237 Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 13:38 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,210 | $141.75 | $313,268.38 |
DisclosureSEC source: 0001467373-19-000017 · wf-form4_154695466302026.xml · nonDerivative · entry 5 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,844 F3 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F5 · price: The transaction was executed in multiple trades at prices ranging from $141.48 to $142.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 13:38 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,400 | $140.98 | $197,376.06 |
DisclosureSEC source: 0001467373-19-000017 · wf-form4_154695466302026.xml · nonDerivative · entry 4 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,054 F3 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $140.48 to $141.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2019 Filed Jan 8, 2019 13:38 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 1,059 | $139.42 | $147,645.78 |
DisclosureSEC source: 0001467373-19-000017 · wf-form4_154695466302026.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,454 Read SEC document |
| January 05, 2019 Filed Jan 8, 2019 13:38 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000017 · wf-form4_154695466302026.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,513 F2 · shares: Grant made pursuant to the Voluntary Equity Investment Program. Read SEC document |
| January 05, 2019 Filed Jan 8, 2019 13:38 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 188 | $139.42 | $26,210.96 |
DisclosureSEC source: 0001467373-19-000017 · wf-form4_154695466302026.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,411 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:40 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 1,712 | $140.34 | $240,262.08 |
DisclosureSEC source: 0001467373-19-000006 · wf-form4_154655159054355.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,223 Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:40 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 5,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000006 · wf-form4_154655159054355.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,935 F1 · kind: Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Read SEC document |
| December 05, 2018 Filed Dec 6, 2018 21:27 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 2,371 | $166.23 | $394,131.33 |
DisclosureSEC source: 0001467373-18-000411 · wf-form4_154413162499163.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,591 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:31 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 39 | $161.19 | $6,286.31 |
DisclosureSEC source: 0001467373-18-000386 · wf-form4_154266304616837.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,220 Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:31 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000386 · wf-form4_154266304616837.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,259 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 21:15 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 166 | $157.85 | $26,202.27 |
DisclosureSEC source: 0001467373-18-000353 · wf-form4_154153889290473.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,078 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 13:05 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,800 | $155.40 | $279,727.92 |
DisclosureSEC source: 0001467373-18-000347 · wf-form4_154081828510959.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,912 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $155.00 to $155.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 13:05 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 3,051 | $154.57 | $471,600.09 |
DisclosureSEC source: 0001467373-18-000347 · wf-form4_154081828510959.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,712 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $154.00 to $154.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 13:05 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,200 | $153.47 | $184,166.04 |
DisclosureSEC source: 0001467373-18-000347 · wf-form4_154081828510959.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,763 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $152.96 to $153.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 20:35 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 4,210 | $157.45 | $662,853.98 |
DisclosureSEC source: 0001467373-18-000337 · wf-form4_154049970596586.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,963 Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 20:35 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000337 · wf-form4_154049970596586.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,173 Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 20:17 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 154 | $171.13 | $26,354.02 |
DisclosureSEC source: 0001467373-18-000305 · wf-form4_153911622277429.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| September 05, 2018 Filed Sep 6, 2018 20:19 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 156 | $168.40 | $26,269.62 |
DisclosureSEC source: 0001467373-18-000282 · wf-form4_153626516405655.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,744 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.